LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Приходи	6.8M -8.1M
Продажби	33M 72M
Марж на печалбата	-11.242
Служители	105
EBITDA	6.7M -5.4M

Дивиденти
By Dow Jones
Следващи печалби	19.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	96M 187M
Предишно отваряне	0
Предишно затваряне	0

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.03.2026 г., 23:01 ч. UTC

Печалби

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5.03.2026 г., 21:54 ч. UTC

Печалби

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5.03.2026 г., 21:35 ч. UTC

Значими двигатели на пазара

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5.03.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5.03.2026 г., 23:33 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5.03.2026 г., 23:27 ч. UTC

Пазарно говорене

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5.03.2026 г., 22:54 ч. UTC

Пазарно говорене

Печалби

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5.03.2026 г., 22:50 ч. UTC

Пазарно говорене

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5.03.2026 г., 22:48 ч. UTC

Печалби

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5.03.2026 г., 22:46 ч. UTC

Печалби

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5.03.2026 г., 22:44 ч. UTC

Печалби

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

5.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

5.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

5.03.2026 г., 21:35 ч. UTC

Печалби

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5.03.2026 г., 21:32 ч. UTC

Печалби

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5.03.2026 г., 21:26 ч. UTC

Печалби

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5.03.2026 г., 21:24 ч. UTC

Печалби

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5.03.2026 г., 21:23 ч. UTC

Печалби

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5.03.2026 г., 21:22 ч. UTC

Печалби

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5.03.2026 г., 21:21 ч. UTC

Печалби

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5.03.2026 г., 21:21 ч. UTC

Печалби

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5.03.2026 г., 21:20 ч. UTC

Печалби

Costco February Net Sales Were $21.69 B >COST

5.03.2026 г., 21:20 ч. UTC

Печалби

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5.03.2026 г., 21:20 ч. UTC

Печалби

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5.03.2026 г., 21:19 ч. UTC

Печалби

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5.03.2026 г., 21:18 ч. UTC

Печалби

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5.03.2026 г., 21:18 ч. UTC

Печалби

Costco 2Q Same-Store Sales Up 7.4% >COST

5.03.2026 г., 21:15 ч. UTC

Печалби

Costco 2Q EPS $4.58 >COST

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.